SPL 3.13% 9.9¢ starpharma holdings limited

Big Pharma or Vulture Capitalists, page-3

  1. 3,305 Posts.
    lightbulb Created with Sketch. 778
    Imagine if Starpharma had used this same VC model back in 2012 to create a start-up company with AstraZeneca to drive the development of AZD0466.

    Guess what the value of Starpharma’s 22.5% of the company would be today after 12 years. A big fat ZERO.

    And they would never have received an initial licence fee and they wouldn’t have received a milestone payment when AZD0466 progressed into Phase One from pre-clinical.

    What a great business model that would have been … for AstraZeneca.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.